SLC2A10 Antikörper (AA 288-335) (FITC)
-
- Target Alle SLC2A10 Antikörper anzeigen
- SLC2A10 (Solute Carrier Family 2 (Facilitated Glucose Transporter), Member 10 (SLC2A10))
-
Bindungsspezifität
- AA 288-335
-
Reaktivität
- Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser SLC2A10 Antikörper ist konjugiert mit FITC
-
Applikation
- Western Blotting (WB), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))
- Kreuzreaktivität
- Ratte
- Homologie
- Human,Mouse,Dog,Cow
- Aufreinigung
- Purified by Protein A.
- Immunogen
- KLH conjugated synthetic peptide derived from human GLUT10
- Isotyp
- IgG
- Top Product
- Discover our top product SLC2A10 Primärantikörper
-
-
- Applikationshinweise
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 μg/μL
- Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
- Haltbarkeit
- 12 months
-
- Target
- SLC2A10 (Solute Carrier Family 2 (Facilitated Glucose Transporter), Member 10 (SLC2A10))
- Andere Bezeichnung
- GLUT10 (SLC2A10 Produkte)
- Synonyme
- SLC2A10 antikoerper, zgc:171488 antikoerper, ATS antikoerper, GLUT10 antikoerper, AA450473 antikoerper, Glut10 antikoerper, solute carrier family 2 member 10 antikoerper, solute carrier family 2 (facilitated glucose transporter), member 10 antikoerper, SLC2A10 antikoerper, slc2a10 antikoerper, Slc2a10 antikoerper
- Hintergrund
-
Synonyms: ATS, GLUT10, Solute carrier family 2, facilitated glucose transporter member 10, Glucose transporter type 10, GLUT-10, SLC2A10
Background: Defects in SLC2A10 are the cause of arterial tortuosity syndrome (ATS) [MIM:208050]. ATS is an autosomal recessive disorder characterized by tortuosity and elongation of major arteries, often resulting in death at young age. Other typical features include aneurysms of large arteries and stenosis of the pulmonary artery, in association with facial features and several connective tissue manifestations such as soft skin and joint laxity. Histopathological findings include fragmentation of elastic fibers in the tunica media of large arteries.
- Gen-ID
- 81031
- UniProt
- O95528
-